Ginsenoside Rg1
[CAS# 22427-39-0]

Identification

• Classification: Biochemical >> Plant extracts
• Name: Ginsenoside Rg1
• Synonyms: (3b,6a,12b)-3,12-Dihydroxydammar-24-ene-6,20- diylbis(beta-D-glucopyranoside); Sanchinoside C1
• Molecular Formula: C₄₂H₇₂O₁₄
• Molecular Weight: 801.01
• CAS Registry Number: 22427-39-0
• EC Number: 244-989-9
• SMILES: CC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O)C

Properties

• Solubility: 10 mM (ethanol)
• Density: 1.3±0.1 g/cm³, Calc.^*
• Index of Refraction: 1.602, Calc.^*
• Boiling Point: 898.5±65.0 °C (760 mmHg), Calc.^*
• Flash Point: 497.2±34.3 °C, Calc.^*

^* Calculated using Advanced Chemistry Development (ACD/Labs) Software.

Safety Data

• Hazard Symbols: GHS07 Warning
• Risk Statements: H302
• Safety Statements: P264-P270-P301+P317-P330-P501

Hazard Classification

Hazard	Class	Category Code	Hazard Statement
Acute toxicity	Acute Tox.	4	H302

Discovery and Applications

Ginsenoside Rg1 is a key active component derived from ginseng, specifically from the roots of Panax ginseng, a plant that has been revered in traditional medicine for centuries. The discovery of ginsenoside Rg1 can be traced back to the early 20th century when researchers began isolating and identifying various saponins from ginseng. Over the years, extensive studies have been conducted to explore the pharmacological properties and therapeutic potential of ginsenoside Rg1, contributing to its recognition as one of the principal bioactive compounds in ginseng.

Chemically, ginsenoside Rg1 is a dammarane-type triterpenoid saponin, characterized by its glycosidic structure, which includes a sugar moiety linked to a dammarane backbone. This unique structure is responsible for its diverse biological activities. Ginsenoside Rg1 can be obtained through extraction from ginseng roots using various methods, including water extraction and organic solvent extraction, followed by purification processes such as chromatography. The focus on ginsenoside Rg1 is attributed to its potent pharmacological effects, which have been extensively studied in vitro and in vivo.

Ginsenoside Rg1 is well-known for its neuroprotective effects. Research indicates that it can enhance cognitive function, improve memory, and protect neurons from damage associated with oxidative stress and neuroinflammation. These properties make ginsenoside Rg1 a potential candidate for developing treatments for neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Studies have demonstrated that ginsenoside Rg1 promotes neuronal survival and enhances synaptic plasticity, thereby improving cognitive performance in animal models.

In addition to its neuroprotective effects, ginsenoside Rg1 exhibits significant anti-inflammatory properties. It has been shown to inhibit the production of pro-inflammatory cytokines and enzymes, which can be beneficial in treating various inflammatory diseases. This anti-inflammatory activity has implications for conditions such as rheumatoid arthritis, asthma, and inflammatory bowel disease. The compound's ability to modulate immune responses further supports its therapeutic potential in managing inflammatory disorders.

Ginsenoside Rg1 also has notable cardioprotective effects. Studies suggest that it can improve cardiac function and protect heart tissues from ischemia-reperfusion injury. The compound enhances blood circulation, reduces oxidative stress, and regulates lipid metabolism, making it a valuable agent for cardiovascular health. Its potential in preventing and treating cardiovascular diseases is an area of active research.

Moreover, ginsenoside Rg1 has been investigated for its role in enhancing physical performance and reducing fatigue. Athletes and individuals engaged in strenuous physical activities have shown interest in ginsenoside Rg1 due to its potential to improve stamina and recovery. Research indicates that it may enhance exercise capacity by promoting energy metabolism and reducing lactic acid accumulation in muscles.

Recent advancements in formulation technologies have further expanded the applications of ginsenoside Rg1. Nanoparticle-based delivery systems are being explored to enhance its bioavailability and target specific tissues more effectively. These innovations may lead to the development of more effective therapeutic formulations containing ginsenoside Rg1 for various health applications.

In summary, ginsenoside Rg1 is a vital bioactive compound derived from Panax ginseng, with a rich history in traditional medicine and a wide array of pharmacological properties. Its neuroprotective, anti-inflammatory, cardioprotective, and performance-enhancing effects make it a promising candidate for various therapeutic applications. As research continues to uncover its mechanisms of action and potential benefits, ginsenoside Rg1 remains a focal point in the quest for natural remedies and health-promoting compounds.

References

2023. Insight Into Foam Properties of Natural Saponins with Low-pH and High-Temperature Tolerance from Xanthoceras sorbifolium Bunge Leaves for Industry Applications. *Food Biophysics*, 18(3).
DOI: 10.1007/s11483-023-09798-3

2012. Biotransformation of ginsenosides Re and Rg1 into ginsenosides Rg2 and Rh1 by recombinant β-glucosidase. *Biotechnology Letters*, 34(4).
DOI: 10.1007/s10529-012-0849-z

2000. Ginsenoside Rc and Rg1 Differentially Modulate NMDA Receptor Subunit mRNA Levels after Intracerebroventricular Infusion in Rats. *Neurochemical Research*, 25(8).
DOI: 10.1023/a:1007634432095